1. Home
  2. NLSP vs VEEE Comparison

NLSP vs VEEE Comparison

Compare NLSP & VEEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NLSP
  • VEEE
  • Stock Information
  • Founded
  • NLSP 2015
  • VEEE 1994
  • Country
  • NLSP Switzerland
  • VEEE United States
  • Employees
  • NLSP N/A
  • VEEE N/A
  • Industry
  • NLSP Biotechnology: Pharmaceutical Preparations
  • VEEE Marine Transportation
  • Sector
  • NLSP Health Care
  • VEEE Industrials
  • Exchange
  • NLSP Nasdaq
  • VEEE Nasdaq
  • Market Cap
  • NLSP 6.9M
  • VEEE 6.4M
  • IPO Year
  • NLSP 2021
  • VEEE 2021
  • Fundamental
  • Price
  • NLSP $1.49
  • VEEE $0.35
  • Analyst Decision
  • NLSP
  • VEEE
  • Analyst Count
  • NLSP 0
  • VEEE 0
  • Target Price
  • NLSP N/A
  • VEEE N/A
  • AVG Volume (30 Days)
  • NLSP 31.2K
  • VEEE 53.2K
  • Earning Date
  • NLSP 05-14-2025
  • VEEE 03-20-2025
  • Dividend Yield
  • NLSP N/A
  • VEEE N/A
  • EPS Growth
  • NLSP N/A
  • VEEE N/A
  • EPS
  • NLSP N/A
  • VEEE N/A
  • Revenue
  • NLSP N/A
  • VEEE $14,388,517.00
  • Revenue This Year
  • NLSP N/A
  • VEEE N/A
  • Revenue Next Year
  • NLSP N/A
  • VEEE N/A
  • P/E Ratio
  • NLSP N/A
  • VEEE N/A
  • Revenue Growth
  • NLSP N/A
  • VEEE N/A
  • 52 Week Low
  • NLSP $1.30
  • VEEE $0.31
  • 52 Week High
  • NLSP $18.40
  • VEEE $0.99
  • Technical
  • Relative Strength Index (RSI)
  • NLSP 42.38
  • VEEE 42.80
  • Support Level
  • NLSP $1.30
  • VEEE $0.32
  • Resistance Level
  • NLSP $1.60
  • VEEE $0.42
  • Average True Range (ATR)
  • NLSP 0.10
  • VEEE 0.03
  • MACD
  • NLSP 0.02
  • VEEE -0.00
  • Stochastic Oscillator
  • NLSP 54.29
  • VEEE 30.00

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

About VEEE Twin Vee PowerCats Co.

Twin Vee PowerCats Co is a designer, manufacturer, and marketer of recreational and commercial power catamaran boats to use for fishing, diving and water skiing and commercial activities including transportation, eco-tours, fishing, and diving expeditions. Its revenue is derived from the sale of boats, motors, and trailers to its independent dealers. It has organized its business into three operating segments: The gas-powered boat segment, which manufactures and distributes gas-powered boats; The electric-powered boat segment, which is developing fully electric boats, through its controlling interest subsidiary, and its franchise segment, which is developing a standard product offering and will be selling franchises across the United States through its wholly-owned subsidiary.

Share on Social Networks: